Prognostic Value of MGMT Promoter Methylation in Glioblastoma Patients Treated With Temozolomide-Based Chemoradiation: A Portuguese Multicentre Study

Oncology Reports - Greece
doi 10.3892/or_00000808
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Spandidos Publications


Related search